There are 2789 resources available
809P - Comprehensive characterization of molecular features distinguishing uterine leiomyoma from leiomyosarcomas
Presenter: Xudong Liu
Session: ePoster Display
810P - Hormonal receptors in uterine leiomyosarcomas: How far is a primary tumor from multiple metastases?
Presenter: Élia Cipriano
Session: ePoster Display
914P - Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC)
Presenter: Divya Kukreja
Session: ePoster Display
915P - Carboplatin in combination with three weekly paclitaxel as first line therapy in patients with recurrent/metastatic head and neck cancers: A regional cancer center experience
Presenter: Pooja Babbar
Session: ePoster Display
813P - Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
Presenter: Kosei Hasegawa
Session: ePoster Display
894P - Investigation of ARID1A mutation and correlation with immunotherapy biomarker in Chinese head and neck cancer patients
Presenter: Jianming gao
Session: ePoster Display
871P - Uptake of concurrent chemoradiation in stage 2 nasopharyngeal cancer (NPC): A population-based outcomes study
Presenter: Teng Hwee Tan
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display
799P - Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial
Presenter: Wei Wei
Session: ePoster Display